The exact cause of endometrial mixed adenocarcinoma is unknown, but certain risk factors have been identified, such as obesity, late menopause, tamoxifen use, and absence of childbearing.
Endometrial mixed adenocarcinoma is typically diagnosed through a combination of pelvic exam, imaging, and biopsy.
Differential diagnosis of endometrial mixed adenocarcinoma includes other types of endometrial cancer, ovarian cancer, and uterine sarcoma.
Treatment for endometrial mixed adenocarcinoma typically involves a combination of hysterectomy, chemotherapy, radiation therapy, and targeted therapy.
The prognosis for endometrial mixed adenocarcinoma depends on the stage at diagnosis, but overall, the five-year survival rate is between 65-80%.